FPI(SZ:300203) Xin Lang Cai Jing·2025-10-30 13:07Core Viewpoint - 聚光科技 is a leading high-end analytical instrument manufacturer in China, focusing on environmental monitoring, industrial process analysis, and laboratory instruments, with strong R&D and technological innovation capabilities [1] Group 1: Financial Performance - In Q3 2025, 聚光科技 achieved revenue of 2.05 billion, ranking 8th in the industry, above the average of 1.64 billion and the median of 0.686 billion, but significantly lower than the top competitors [2] - The main business revenue composition includes instruments, related software, and consumables at 896 million, accounting for 69.24%, while operational services, testing services, and consulting services contributed 213 million, or 16.42% [2] - The net profit for the period was -98.18 million, ranking 27th in the industry, far below the average net profit of 87.63 million and the median of 20.92 million [2] Group 2: Financial Ratios - As of Q3 2025, 聚光科技's debt-to-asset ratio was 64.89%, slightly down from 65.16% year-on-year but still above the industry average of 43.61% [3] - The gross profit margin for Q3 2025 was 39.69%, down from 44.37% year-on-year but higher than the industry average of 25.59% [3] Group 3: Management Compensation - The chairman, 顾海涛, received a salary of 2.1098 million, an increase of 246,700 from the previous year [4] - The general manager, 韩双来, saw a significant salary increase from 1.8931 million to 3.2224 million, an increase of 1.3293 million [4] Group 4: Shareholder Information - As of September 30, 2025, the number of A-share shareholders increased by 13.30% to 23,000, while the average number of shares held per shareholder decreased by 11.74% to 19,500 [5] - The top ten circulating shareholders included Hong Kong Central Clearing Limited and 瑞远成长价值混合A, with notable changes in their holdings [5] Group 5: Market Outlook - 华西证券 noted that 聚光科技's performance is under short-term pressure, with a revenue decline of 11.10% year-on-year for Q1-Q3 2025, and a shift from profit to loss in net profit [6] - The company is focusing on high-end scientific instruments and expanding into semiconductor and life sciences sectors, with expected revenue growth in the coming years [6][7]